Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment

NCT05152004 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Pariet
DRUG: Amolin
DRUG: Klaricid
DRUG: Flagyl

Sponsor

Chang Gung Memorial Hospital